CRI Spotlight Series: Use of Machine Learning and EEG Technology to Objectively Quantify the Psychoactive Effects of Cannabis, Quickly and Cost Effectively

views comments

CRI Spotlight Series—a new platform highlighting cutting-edge, real-world cannabis research that bridges science, innovation, and public impact.

Our featured guest is Israel Gasperin, engineering scientist and founder and CEO of Zentrela, whose EEG-based technology is redefining how we measure the psychoactive effects of cannabis.

After eight years of large-scale, IRB-approved human trials and more than 20,000 EEG scans, Israel Gasperin will share how Zentrela’s technology:

Uses machine learning to quantify and accelerate research on cannabis’ psychoactive effects
Enables rigorous EEG-based studies by non-specialists through portable, user-friendly tools
Has been used in collaborations with hospitals, universities, and R&D labs exploring next-generation cannabis products

…Read more Less…

Tags

CRI Spotlight Series: Use of Machine Learning and EEG Technology to Objectively Quantify the Psychoactive Effects of Cannabis, Quickly and Cost Effectively

Related Media